Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Multi-center, Phase I Study of TECLens Corneal Crosslinking System for Correction of Refractive Error in Patients of Presbyopia Age.

NCT07208604 is registered in ClinicalTrials.gov with TECLens, Inc. as lead sponsor.

NCT NCT07208604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07208604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Multi-center, Phase I Study of TECLens Corneal Crosslinking System for Correction of Refractive Error in Patients of Presbyopia Age.
Lead sponsor
TECLens, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
August 31, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia